276 related articles for article (PubMed ID: 33070148)
1. Silencing of Long Non-Coding RNA X Inactive Specific Transcript (Xist) Contributes to Suppression of Bronchopulmonary Dysplasia Induced by Hyperoxia in Newborn Mice via microRNA-101-3p and the transforming growth factor-beta 1 (TGF-β1)/Smad3 Axis.
Yuan W; Liu X; Zeng L; Liu H; Cai B; Huang Y; Tao X; Mo L; Zhao L; Gao C
Med Sci Monit; 2020 Oct; 26():e922424. PubMed ID: 33070148
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of lncRNA H19 in Regulating Pulmonary Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia Newborn Mice.
Zhang L; Wang P; Shen Y; Huang T; Hu X; Yu W
Am J Perinatol; 2022 Jul; 39(10):1089-1096. PubMed ID: 33285606
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1.
Hu Y; Xie L; Yu J; Fu H; Zhou D; Liu H
Mol Med; 2019 Dec; 26(1):3. PubMed ID: 31892308
[TBL] [Abstract][Full Text] [Related]
4. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
5. LINC01116 regulates proliferation, migration, and apoptosis of keloid fibroblasts by the TGF-β1/SMAD3 signaling via targeting miR-3141.
Wu D; Zhou J; Tan M; Zhou Y
Anal Biochem; 2021 Aug; 627():114249. PubMed ID: 34048784
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia.
Bao T; Liu X; Hu J; Ma M; Li J; Cao L; Yu B; Cheng H; Zhao S; Tian Z
Inflammation; 2024 Apr; 47(2):469-482. PubMed ID: 37917328
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of long non-coding RNAs in hyperoxia-induced bronchopulmonary dysplasia.
Bao TP; Wu R; Cheng HP; Cui XW; Tian ZF
Cell Biochem Funct; 2016 Jul; 34(5):299-309. PubMed ID: 27137150
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A
Chen XQ; Wu SH; Luo YY; Li BJ; Li SJ; Lu HY; Jin R; Sun ZY
Inflammation; 2017 Dec; 40(6):2094-2108. PubMed ID: 28819748
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CASC2 targets CAV1 by competitively binding with microRNA-194-5p to inhibit neonatal lung injury.
Ji L; Liu Z; Dong C; Wu D; Yang S; Wu L
Exp Mol Pathol; 2021 Feb; 118():104575. PubMed ID: 33212124
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis.
Lang Y; Zhang H; Yu H; Li Y; Liu X; Li M
Bioengineered; 2022 Jan; 13(1):930-940. PubMed ID: 34967706
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST enhanced TGF-β2 expression by targeting miR-141-3p to promote pancreatic cancer cells invasion.
Sun J; Zhang Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213574
[TBL] [Abstract][Full Text] [Related]
13. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway : XIST promotes ALI via miR-132-3p/MAPK14 axis.
Li C; Liu JH; Su J; Lin WJ; Zhao JQ; Zhang ZH; Wu Q
Mol Cell Biochem; 2021 Dec; 476(12):4217-4229. PubMed ID: 34346000
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
17. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
18. Involvement of Hdac3-mediated inhibition of microRNA cluster 17-92 in bronchopulmonary dysplasia development.
Wang D; Hong H; Li XX; Li J; Zhang ZQ
Mol Med; 2020 Nov; 26(1):99. PubMed ID: 33143661
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor-β1 in neonatal rats with hyperoxia-induced bronchopulmonary dysplasia and its relationship with lung development.
Yan B; Zhong W; He QM; Zhang SY; Yu JK; Pan YL
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173325
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
